journal article·2025-02-11Open access

Evaluating Bioassays for the Determination of Simvastatin’s Osteogenic Activity: A Systematic Review

Lara Steiner Back, Isabella Schönhofen Manso, Mariane Beatriz Sordi, Gabriel Leonardo Magrin, Águedo Aragonês, Ricardo de Souza Magini, Reinhard Gruber, Ariadne Cristiane Cabral Cruz

Abstract

Objective: Osteogenic differentiation is a complex process, and its analysis requires several biomarkers. Allied with this, there are no standardized bioassays to monitor the activity of simvastatin in osteogenesis in vitro. Therefore, identifying the most efficient and sensitive bioassays may enhance the quality of in vitro studies, bridging the gap with in vivo findings, saving time and resources, and benefiting the community. This systematic review aimed to determine the most efficient bioassay for simvastatin’s osteogenic activity in vitro, in terms of sensitivity. Materials and Methods: In vitro studies evaluating undifferentiated mesenchymal cells treated with simvastatin were considered eligible. References were selected in a two-phase process. Electronic databases and the grey literature were screened up to September 2023. The Office of Health Assessment and Translation (OHAT) tool was used to assess the risk of bias. Certainty in cumulative evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria. Data were analyzed considering extracellular matrix mineralization, alkaline phosphatase, and the expression of potential target genes, such as bone morphogenetic protein-2 (BMP-2), collagen type I, Runt-related transcription factor 2, osterix, osteocalcin, and osteopontin. Results: Fourteen studies were included. A “probably low” or a “definitely low” risk of bias was assigned to the included studies. The simvastatin concentration ranged from 0.1 nM to 10 µM. Considering a minimum 4-fold increase, simvastatin caused robust mineralization of the extracellular matrix in four studies (4.0-, 4.4-, 5.0-, and 39.5-fold). Moreover, simvastatin substantially increased BMP-2 expression in mesenchymal cells in three studies (4-, 11-, and 19-fold). Conclusion: Therefore, mineralization of the extracellular matrix and BMP-2 expression in mesenchymal cells are the most efficient bioassays for determining the osteogenic activity of simvastatin in vitro (high certainty level). These findings provide a standardized approach that can enhance the reliability and comparability of in vitro studies, bridging the gap with in vivo research and optimizing resources in the field of bone regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipoproteins and Cardiovascular Health · Bone Metabolism and Diseases · Bone health and osteoporosis research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Post-Graduation Program of Dentistry, Center for Education and Research on Dental Implants, Federal University of Santa Catarina, Florianópolis 88053-701, Brazil

Department of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, 1090 Vienna, Austria

Applied Virology Laboratory, Federal University of Santa Catarina, Florianópolis 88053-701, Brazil

Funding

a scholarship from Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC—Research and Innovation Support Foundation of Santa Catarina State), Brazil · scholarships from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (CAPES—Coordination for the Improvement of Higher Education Personnel), Brazil · Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC—Research and Innovation Support Foundation of Santa Catarina State), Brazil

References (45)

Show source-provided references
1. Guided Bone Regeneration in Staged Vertical and Horizontal Bone Augmentation Using Platelet-Rich Fibrin Associated with Bone Grafts: A Retrospective Clinical Study10.1186/s40729-020-00266-y ↗
2. A 5-Year Cohort Study on Early Implant Placement with Guided Bone Regeneration or Alveolar Ridge Preservation with Connective Tissue Graft10.1111/cid.12948 ↗
3. Complications Following Autologous Bone Graft Harvesting from the Iliac Crest and Using the RIA: A Systematic Review10.1016/j.injury.2011.06.015 ↗
4. Limitations of Autograft and Allograft: New Synthetic Solutions10.3928/0147-7447-20020502-04 ↗
5. Sun, X., Liu, C., Shi, Y., Li, C., Sun, L., Hou, L., and Wang, X. (2019). The Assessment of Xenogeneic Bone Immunotoxicity and Risk Management Study. Biomed. Eng. Online, 18.10.1186/s12938-019-0729-z ↗
6. Guided Bone Regeneration: Biological Principle and Therapeutic Applications10.1111/j.1600-0501.2010.01922.x ↗
7. Bone Regeneration Using the Principle of Guided Tissue Regeneration10.1111/j.1600-051X.1991.tb02322.x ↗
8. Stem Cells, Tissue Engineering and Periodontal Regeneration10.1111/adj.12100 ↗
9. Stimulation of Bone Formation in Vitro and in Rodents by Statins
10. Regulation of the Mevalonate Pathway10.1038/343425a0 ↗
11. Statins and Osteoporosis: New Role for Old Drugs10.1211/jpp.58.1.0002 ↗
12. Oh, J.-S., Park, J.-S., and Lee, E.-J. (2021). Enhanced Effect of Polyethyleneimine-Modified Graphene Oxide and Simvastatin on Osteogenic Differentiation of Murine Bone Marrow-Derived Mesenchymal Stem Cells. Biomedicines, 9.10.3390/biomedicines9050501 ↗
13. Wu, S.-C., Chang, C.-H., Chang, L.-H., Wu, C.-W., Chen, J.-W., Chen, C.-H., Lin, Y.-S., Chang, J.-K., and Ho, M.-L. (2021). Simvastatin Enhances the Chondrogenesis But Not the Osteogenesis of Adipose-Derived Stem Cells in a Hyaluronan Microenvironment. Biomedicines, 9.10.3390/biomedicines9050559 ↗
14. The Role of Simvastatin in the Osteogenesis of Injectable Tissue-Engineered Bone Based on Human Adipose-Derived Stromal Cells and Platelet-Rich Plasma10.1016/j.biomaterials.2010.03.037 ↗
15. Simvastatin Enhances Rho/Actin/Cell Rigidity Pathway Contributing to Mesenchymal Stem Osteogenic Differentiation
16. Simvastatin Promotes Rat Achilles Tendon-Bone Interface Healing by Promoting Osteogenesis and Chondrogenic Differentiation of Stem Cells10.1007/s00441-022-03714-w ↗
17. Simvastatin-Hydroxyapatite Coatings Prevent Biofilm Formation and Improve Bone Formation in Implant-Associated Infections
18. Compactin and Simvastatin, but Not Pravastatin, Induce Bone Morphogenetic Protein-2 in Human Osteosarcoma Cells10.1006/bbrc.2000.2697 ↗
19. Simvastatin, an HMG-CoA Reductase Inhibitor, Reduced the Expression of Matrix Metalloproteinase-9 (Gelatinase B) in Osteoblastic Cells and HT1080 Fibrosarcoma Cells10.1254/jphs.94.403 ↗
20. Simvastatin and Atorvastatin Enhance Gene Expression of Collagen Type 1 and Osteocalcin in Primary Human Osteoblasts and MG-63 Cultures10.1002/jcb.21259 ↗
21. Simvastatin Induces Osteogenic Differentiation of MSCs via Wnt/β-Catenin Pathway to Promote Fracture Healing
22. Shao, P.-L., Wu, S.-C., Lin, Z.-Y., Ho, M.-L., Chen, C.-H., and Wang, C.-Z. (2019). Alpha-5 Integrin Mediates Simvastatin-Induced Osteogenesis of Bone Marrow Mesenchymal Stem Cells. Int. J. Mol. Sci., 20.10.3390/ijms20030506 ↗
23. Estrogen Receptor Mediates Simvastatin-Stimulated Osteogenic Effects in Bone Marrow Mesenchymal Stem Cells10.1016/j.bcp.2015.09.018 ↗
24. 20(S)-Hydroxycholesterol and Simvastatin Synergistically Enhance Osteogenic Differentiation of Marrow Stromal Cells and Bone Regeneration by Initiation of Raf/MEK/ERK Signaling10.1007/s10856-019-6284-0 ↗
25. Statin-Induced Calcification in Human Mesenchymal Stem Cells Is Cell Death Related10.1111/j.1582-4934.2008.00545.x ↗
26. Simvastatin Induces Osteogenic Differentiation and Suppresses Adipogenic Differentiation in Primarily Cultured Human Adipose-Derived Stem Cells10.4062/biomolther.2009.17.4.353 ↗
27. Osteogenic Differentiation Effect of BMP-9 with Phenamil and Simvastatin on Intact Human Amniotic Epithelial Stem Cells10.52547/ibj.3748 ↗
28. Simvastatin Promotes Osteogenic Differentiation of Mouse Embryonic Stem Cells via Canonical Wnt/β-Catenin Signaling10.1007/s10059-011-0107-6 ↗
29. Simvastatin Induces Osteogenic Differentiation of Murine Embryonic Stem Cells10.1002/jbmr.163 ↗
30. Sabandal, M.M.I., Schäfer, E., Petsching, S., Jung, S., Kleinheinz, J., and Sielker, S. (2022). Pleiotropic Effects on Proliferation and Mineralization of Primary Human Adipose Tissue-Derived Stromal Cells Induced by Simvastatin. Open Biol., 12.10.1098/rsob.210337 ↗
31. The Effects of Simvastatin on Cellular Viability, Stemness and Osteogenic Differentiation Using 3-Dimensional Cultures of Stem Cells and Osteoblast-like Cells10.17219/acem/94162 ↗
32. A Guide to Systematic Reviews10.1034/j.1600-051X.29.s3.15.x ↗
33. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews10.1136/bmj.n71 ↗
34. National Toxicology Program—Office of Health Assessment and Translation NTP-OHAT (2019). Handbook for Conducting a Literature-Based Health Assessment Using OHAT Approach for Systematic Review and Evidence Integration, National Toxicology Program—US Department of Health and Human Services.
35. Genotoxicity of Radiofrequency Electromagnetic Fields: Protocol for a Systematic Review of in Vitro Studies10.1016/j.envint.2021.106386 ↗
36. GRADE Guidelines: 1. Introduction-GRADE Evidence Profiles and Summary of Findings Tables10.1016/j.jclinepi.2010.04.026 ↗
37. Back, L.S. (2021). Efeitos In Vitro da Sinvastatina na Osteoindução de Células Indiferenciadas: Uma Revisão Sistemática. [Master’s Thesis, Universidade Federal de Santa Catarina].
38. Statin-Induced Ras Activation Integrates the Phosphatidylinositol 3-Kinase Signal to Akt and MAPK for Bone Morphogenetic Protein-2 Expression in Osteoblast Differentiation10.1074/jbc.M606706200 ↗
39. Integration of Ca2+ Signaling Regulates the Breast Tumor Cell Response to Simvastatin and Doxorubicin10.1038/s41388-018-0329-6 ↗
40. Aquino-Martínez, R., Artigas, N., Gámez, B., Rosa, J.L., and Ventura, F. (2017). Extracellular Calcium Promotes Bone Formation from Bone Marrow Mesenchymal Stem Cells by Amplifying the Effects of BMP-2 on SMAD Signalling. PLoS ONE, 12.10.1371/journal.pone.0178158 ↗
41. Hammel, C., Pandis, N., Pieper, D., and Faggion, C.M. (2022). Methodological Assessment of Systematic Reviews of In-Vitro Dental Studies. BMC Med. Res. Methodol., 22.10.1186/s12874-022-01575-z ↗
42. Reporting Quality in Systematic Reviews of in Vitro Studies: A Systematic Review10.1080/03007995.2019.1607270 ↗
43. GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations10.1136/bmj.39489.470347.AD ↗
44. The Impact of Simvastatin Intervention on the Healing of Bone, Soft Tissue, and TMJ Cartilage in Dentistry: A Systematic Review and Meta-Analysis10.1186/s40729-019-0168-4 ↗
45. Leutner, M., Butylina, M., Matzhold, C., Klimek, P., Cuhaj, C., Bellach, L., Baumgartner-Parzer, S., Reiter, B., Preindl, K., and Kautzky, A. (2023). Simvastatin Therapy in Higher Dosages Deteriorates Bone Quality: Consistent Evidence from Population-Wide Patient Data and Interventional Mouse Studies. Biomed. Pharmacother., 158.10.1016/j.biopha.2022.114089 ↗